NCT06400784View on ClinicalTrials.gov

Hypertensive Heart Failure Treatment in SSA

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 25, 2022

Primary Completion Date

February 26, 2024

Study Completion Date

March 26, 2024

Conditions
A Feasibility Study on Hypertensive Heart Failure Treatment
Interventions
DRUG

Isosorbide Dinitrate

Isosorbide dinitrate (5mg bd) and Hydralazine (25mg bd) will be added on top of conventional heart failure medications.

Trial Locations (1)

90001

University of Abuja Teaching Hospital, Abuja

All Listed Sponsors
collaborator

University of Cambridge

OTHER

lead

University of Abuja

OTHER